Sony Forecasts Gaming Sales Drop as PS5 Ages and Memory Chip Costs Rise
Sony forecast a decline in annual sales for its gaming business as the PlayStation 5 enters a more mature stage of its life cycle and the company faces pressure from rising memory chip prices. Sony expects gaming sales to fall 6% to 4.42 trillion yen, or about $28 billion, as hardware sales slow and the […]
Competition From Google, AMD and Custom AI Chips Puts Pressure on Nvidia’s Market Dominance
Nvidia is still the dominant force in artificial intelligence chips, but investors are becoming more cautious as competition grows from both traditional semiconductor rivals and major technology companies developing their own AI hardware. Bloomberg reported that Nvidia shares fell about 7% after closing at a record high on April 27, even while the broader Philadelphia […]
Intellia Jumps After Gene-Editing Therapy Succeeds in Pivotal Trial for Rare Swelling Disorder
Intellia Therapeutics rose sharply after reporting successful late-stage results for its experimental gene-editing treatment for hereditary angioedema, a rare disorder that causes dangerous and recurring swelling attacks. The company’s therapy met the main goal of its pivotal trial, helping drive shares higher. The treatment is important because it represents a major step forward for in […]
New Offshore Wind Projects Advance Despite Trump’s Push to Shut Down U.S. Wind Expansion
Offshore wind projects are continuing to take shape along the U.S. East Coast even as President Donald Trump tries to stop the American offshore wind industry from moving forward. Seemingly, there are three of the five wind farms in the region, two fully operational, two nearly complete, and one about halfway built. The physical build-out […]
Moderna Begins Late-Stage Bird Flu Vaccine Trial in U.S. and U.K.
Moderna has begun a late-stage clinical trial of its experimental bird flu vaccine in the United States and the United Kingdom, marking a significant milestone in the effort to prepare for a possible future influenza pandemic. This is the first pandemic bird flu vaccine built with mRNA technology to reach a late-stage trial, moving the […]
Caterpillar Acquires Electric Tractor Startup Monarch in Bet on Autonomous Agriculture
Caterpillar has acquired Monarch Tractor, a California startup known for building self-driving electric tractors, in a deal that signals the industrial giant’s interest in expanding deeper into agricultural automation and cleaner equipment. The acquisition gives Caterpillar control of a company once viewed as one of the most promising startups in the ag-tech space, especially for […]
Blue Owl Expands Healthcare Real Estate Bet With $2.4 Billion Deal for Sila Realty Trust
Blue Owl Capital has agreed to acquire Sila Realty Trust in an all-cash deal valued at about $2.4 billion, expanding its push into healthcare real estate at a time when alternative asset managers are looking for steadier, income-producing assets.The acquisition will be made through Blue Owl’s real assets division and includes Sila’s portfolio of 137 […]
Uldouz Wallace’s PROTECT Act Advances in Arizona as U.S. and Global Adoption Accelerates
Arizona’s PROTECT Act, introduced by Arizona State Representative Nick Kupper following outreach from Uldouz Wallace, is advancing toward final approval, marking a critical step in addressing the growing global crisis of online exploitation, non-consensual content, and AI-generated deepfake abuse. The legislation has already passed out of the Arizona State House with a bipartisan supermajority and […]
New AWS Platform Aims to Shrink Drug Discovery Timelines From Months to Weeks
Amazon Web Services has launched a new artificial intelligence platform designed to accelerate one of the slowest parts of pharmaceutical research: early-stage drug discovery. The new product, called Amazon Bio Discovery, is meant to help scientists run complex computational workflows without writing code, making advanced AI tools easier to use for researchers who may not […]
Lilly’s New Obesity Pill Wins Approval, but FDA Demands Extra Studies on Liver and Heart Risks
Eli Lilly’s newly approved weight-loss pill has cleared an important regulatory hurdle, but the U.S. Food and Drug Administration is requiring the company to carry out additional safety studies after launch, showing that regulators still want closer scrutiny of the medicine’s risks. Apparently, FDA asked Lilly for more data on possible liver injury linked to […]
